Internalization and subcellular fate of aptamer and peptide dual-functioned nanoparticles

References

• Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008;7:771–82
   PubMed Web of Science ®Google Scholar
• Farokhzad OC, Langer R. Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev 2006;58:1456–59
   PubMed Web of Science ®Google Scholar
• Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 2010;7:653–64
   PubMed Web of Science ®Google Scholar
• Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007;2:751–60
   PubMed Web of Science ®Google Scholar
• Agarwal S, Sane R, Oberoi R, et al. Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain. Expert Rev Mol Med 2011;13:e17
   PubMed Web of Science ®Google Scholar
• Gao H, Pang Z, Jiang X. Targeted delivery of nano-therapeutics for major disorders of the central nervous system. Pharmaceut Res 2013;30:2485–98
   PubMed Web of Science ®Google Scholar
• Du J, Lu WL, Ying X, et al. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals. Mol Pharm 2009;6:905–17
   PubMed Web of Science ®Google Scholar
• Gao H, Qian J, Cao S, et al. Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles. Biomaterials 2012;33:5115–23
   PubMed Web of Science ®Google Scholar
• Yan H, Wang L, Wang J, et al. Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier. ACS Nano 2012;6:410–20
   PubMed Web of Science ®Google Scholar
• Li J, Feng L, Fan L, et al. Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides. Biomaterials 2011;32:4943–50
   PubMed Web of Science ®Google Scholar
• Teng Y, Girvan AC, Casson LK, et al. AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin. Cancer Res 2007;67:10491–500
   PubMed Web of Science ®Google Scholar
• Chithrani BD, Ghazani AA, Chan WC. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006;6:662–8
   PubMed Web of Science ®Google Scholar
• Dash BC, Rethore G, Monaghan M, et al. The influence of size and charge of chitosan/polyglutamic acid hollow spheres on cellular internalization, viability and blood compatibility. Biomaterials 2010;31:8188–97
   Google Scholar
• Jiang W, Kim BY, Rutka JT, Chan WC. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 2008;3:145–50
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Azadmanesh K, Shokrgozar MA, et al. Effect of nanoparticles on the cell life cycle. Chem Rev 2011;111:3407–32
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Bhattacharya R, Curley S, et al. Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis. Proc Natl Acad Sci USA 2010;107:14541–6
   PubMed Web of Science ®Google Scholar
• Mickler FM, Mockl L, Ruthardt N, et al. Tuning nanoparticle uptake: live-cell imaging reveals two distinct endocytosis mechanisms mediated by natural and artificial EGFR targeting ligand. Nano Lett 2012;12:3417–23
   PubMed Web of Science ®Google Scholar
• Gao H, Yang Z, Zhang S, et al. Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization. Sci Rep 2013;3:2534
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Lynch I, Ejtehadi MR, et al. Protein-nanoparticle interactions: opportunities and challenges. Chem Rev 2011;111:5610–37
   PubMed Web of Science ®Google Scholar
• Pang Z, Lu W, Gao H, et al. Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. J Control Rel 2008;128:120–7
   PubMed Web of Science ®Google Scholar
• Gao H, Pan S, Yang Z, et al. A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein. Biomaterials 2011;32:8669–75
   PubMed Web of Science ®Google Scholar
• Lu W, Zhang Y, Tan YZ, et al. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J Control Rel 2005;107:428–48
   PubMed Web of Science ®Google Scholar
• Chang J, Jallouli Y, Kroubi M, et al. Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier. Int J Pharmaceut 2009;379:285–92
   PubMed Web of Science ®Google Scholar
• Lu W, Sun Q, Wan J, et al. Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. Cancer Res 2006;66:11878–87
   PubMed Web of Science ®Google Scholar
• Nam HY, Kwon SM, Chung H, et al. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J Control Rel 2009;135:259–67
   PubMed Web of Science ®Google Scholar
• Pang Z, Gao H, Yu Y, et al. Brain delivery and cellular internalization mechanisms for transferrin conjugated biodegradable polymersomes. Int J Pharmaceut 2011;415:284–92
   PubMed Web of Science ®Google Scholar
• Jiang S, Rhee SW, Gleeson PA, Storrie B. Capacity of the Golgi apparatus for cargo transport prior to complete assembly. Mol Biol Cell 2006;17:4105–17
   PubMed Web of Science ®Google Scholar
• Liu J, Shapiro JI. Endocytosis and signal transduction: basic science update. Biol Res Nurs 2003;5:117–28
   PubMedGoogle Scholar
• Xin H, Jiang X, Gu J, et al. Angiopep-conjugated poly(ethylene glycol)-co-poly(epsilon-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials 2011;32:4293–305
   PubMed Web of Science ®Google Scholar
• Hwang DW, Ko HY, Lee JH, et al. A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. J Nucl Med 2010;51:98–105
   PubMed Web of Science ®Google Scholar
• Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 2004;56:1649–59
   PubMed Web of Science ®Google Scholar
• Liu Y, Lu W. Recent advances in brain tumor-targeted nano-drug delivery systems. Expert Opin Drug Deliv 2012;9:671–86
   PubMed Web of Science ®Google Scholar
• Pardridge WM. Vector-mediated drug delivery to the brain. Adv Drug Deliv Rev 1999;36:299–321
   PubMed Web of Science ®Google Scholar
• Shieh YA, Yang SJ, Wei MF, Shieh MJ. Aptamer-based tumor-targeted drug delivery for photodynamic therapy. ACS Nano 2010;4:1433–42
   PubMed Web of Science ®Google Scholar
• Guo J, Gao X, Su L, et al. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials 2011;32:8010–20
   PubMed Web of Science ®Google Scholar
• Bareford LM, Swaan PW. Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev 2007;59:748–58
   PubMed Web of Science ®Google Scholar
• Doherty GJ, McMahon HT. Mechanisms of endocytosis. Ann Rev Biochem 2009;78:857–902
   PubMed Web of Science ®Google Scholar
• Dos ST, Varela J, Lynch I, et al. Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One 2011;6:e24438
   PubMed Web of Science ®Google Scholar
• Parton RG, Richards AA. Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms. Traffic 2003;4:724–38
   PubMed Web of Science ®Google Scholar
• Ozment TR, Goldman MP, Kalbfleisch JH, Williams DL. Soluble glucan is internalized and trafficked to the Golgi apparatus in macrophages via a clathrin mediated, lipid raft regulated mechanism. J Pharmacol Exp Therapeut 2012;342:808–15
   PubMed Web of Science ®Google Scholar
• Reilly MJ, Larsen JD, Sullivan MO. Polyplexes traffic through caveolae to the Golgi and endoplasmic reticulum en route to the nucleus. Mol Pharm 2012;9:1280–90
   PubMed Web of Science ®Google Scholar